These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
429 related articles for article (PubMed ID: 11535708)
1. Milk intake, circulating levels of insulin-like growth factor-I, and risk of colorectal cancer in men. Ma J; Giovannucci E; Pollak M; Chan JM; Gaziano JM; Willett W; Stampfer MJ J Natl Cancer Inst; 2001 Sep; 93(17):1330-6. PubMed ID: 11535708 [TBL] [Abstract][Full Text] [Related]
2. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. Ma J; Pollak MN; Giovannucci E; Chan JM; Tao Y; Hennekens CH; Stampfer MJ J Natl Cancer Inst; 1999 Apr; 91(7):620-5. PubMed ID: 10203281 [TBL] [Abstract][Full Text] [Related]
3. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. Kaaks R; Toniolo P; Akhmedkhanov A; Lukanova A; Biessy C; Dechaud H; Rinaldi S; Zeleniuch-Jacquotte A; Shore RE; Riboli E J Natl Cancer Inst; 2000 Oct; 92(19):1592-600. PubMed ID: 11018095 [TBL] [Abstract][Full Text] [Related]
4. Circulating insulin-like growth factor-related biomarkers: Correlates and responses to calcium supplementation in colorectal adenoma patients. Um CY; Fedirko V; Flanders WD; Höflich C; Wirthgen E; Bostick RM Mol Carcinog; 2017 Sep; 56(9):2127-2134. PubMed ID: 28467661 [TBL] [Abstract][Full Text] [Related]
5. A prospective study of plasma C-peptide and colorectal cancer risk in men. Ma J; Giovannucci E; Pollak M; Leavitt A; Tao Y; Gaziano JM; Stampfer MJ J Natl Cancer Inst; 2004 Apr; 96(7):546-53. PubMed ID: 15069117 [TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. Chan JM; Stampfer MJ; Ma J; Gann P; Gaziano JM; Pollak M; Giovannucci E J Natl Cancer Inst; 2002 Jul; 94(14):1099-106. PubMed ID: 12122101 [TBL] [Abstract][Full Text] [Related]
7. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study. Stattin P; Bylund A; Rinaldi S; Biessy C; Déchaud H; Stenman UH; Egevad L; Riboli E; Hallmans G; Kaaks R J Natl Cancer Inst; 2000 Dec; 92(23):1910-7. PubMed ID: 11106682 [TBL] [Abstract][Full Text] [Related]
8. IGF-1, IGF-2 and IGFBP-3 in prediagnostic serum: association with colorectal cancer in a cohort of Chinese men in Shanghai. Probst-Hensch NM; Yuan JM; Stanczyk FZ; Gao YT; Ross RK; Yu MC Br J Cancer; 2001 Nov; 85(11):1695-9. PubMed ID: 11742490 [TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor I, binding proteins -1 and -3, risk of type 2 diabetes and macronutrient intakes in men. Similä ME; Kontto JP; Virtamo J; Hätönen KA; Valsta LM; Sundvall J; Männistö S Br J Nutr; 2019 Apr; 121(8):938-944. PubMed ID: 30898176 [TBL] [Abstract][Full Text] [Related]
10. Determinants of circulating insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations in a cohort of Singapore men and women. Probst-Hensch NM; Wang H; Goh VH; Seow A; Lee HP; Yu MC Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):739-46. PubMed ID: 12917205 [TBL] [Abstract][Full Text] [Related]
11. Dietary and lifestyle correlates of plasma insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3): the multiethnic cohort. DeLellis K; Rinaldi S; Kaaks RJ; Kolonel LN; Henderson B; Le Marchand L Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1444-51. PubMed ID: 15342444 [TBL] [Abstract][Full Text] [Related]
12. A cross-sectional analysis of the association between diet and insulin-like growth factor (IGF)-I, IGF-II, IGF-binding protein (IGFBP)-2, and IGFBP-3 in men in the United Kingdom. Young NJ; Metcalfe C; Gunnell D; Rowlands MA; Lane JA; Gilbert R; Avery KN; Davis M; Neal DE; Hamdy FC; Donovan J; Martin RM; Holly JM Cancer Causes Control; 2012 Jun; 23(6):907-17. PubMed ID: 22527168 [TBL] [Abstract][Full Text] [Related]
13. Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies. Rinaldi S; Cleveland R; Norat T; Biessy C; Rohrmann S; Linseisen J; Boeing H; Pischon T; Panico S; Agnoli C; Palli D; Tumino R; Vineis P; Peeters PH; van Gils CH; Bueno-de-Mesquita BH; Vrieling A; Allen NE; Roddam A; Bingham S; Khaw KT; Manjer J; Borgquist S; Dumeaux V; Torhild Gram I; Lund E; Trichopoulou A; Makrygiannis G; Benetou V; Molina E; Donate Suárez I; Barricarte Gurrea A; Gonzalez CA; Tormo MJ; Altzibar JM; Olsen A; Tjonneland A; Grønbaek H; Overvad K; Clavel-Chapelon F; Boutron-Ruault MC; Morois S; Slimani N; Boffetta P; Jenab M; Riboli E; Kaaks R Int J Cancer; 2010 Apr; 126(7):1702-15. PubMed ID: 19810099 [TBL] [Abstract][Full Text] [Related]
14. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk. Schernhammer ES; Holly JM; Pollak MN; Hankinson SE Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352 [TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor (IGF)-I, IGF-II, IGF binding protein-3, and risk of colorectal cancer: a nested case-control study in the Japan Collaborative Cohort study. Suzuki S; Kojima M; Tokudome S; Suzuki K; Ozasa K; Ito Y; Inaba Y; Tajima K; Nakachi K; Watanabe Y; Tamakoshi A; Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():45-9. PubMed ID: 20553081 [TBL] [Abstract][Full Text] [Related]
16. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Giovannucci E; Pollak MN; Platz EA; Willett WC; Stampfer MJ; Majeed N; Colditz GA; Speizer FE; Hankinson SE Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):345-9. PubMed ID: 10794477 [TBL] [Abstract][Full Text] [Related]
17. The association between diet and serum concentrations of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3 in the European Prospective Investigation into Cancer and Nutrition. Crowe FL; Key TJ; Allen NE; Appleby PN; Roddam A; Overvad K; Grønbaek H; Tjønneland A; Halkjaer J; Dossus L; Boeing H; Kröger J; Trichopoulou A; Dilis V; Trichopoulos D; Boutron-Ruault MC; De Lauzon B; Clavel-Chapelon F; Palli D; Berrino F; Panico S; Tumino R; Sacerdote C; Bueno-de-Mesquita HB; Vrieling A; van Gils CH; Peeters PH; Gram IT; Skeie G; Lund E; Rodríguez L; Jakszyn P; Molina-Montes E; Tormo MJ; Barricarte A; Larrañaga N; Khaw KT; Bingham S; Rinaldi S; Slimani N; Norat T; Gallo V; Riboli E; Kaaks R Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1333-40. PubMed ID: 19423514 [TBL] [Abstract][Full Text] [Related]
18. Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Douglas JB; Silverman DT; Pollak MN; Tao Y; Soliman AS; Stolzenberg-Solomon RZ Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2298-306. PubMed ID: 20699371 [TBL] [Abstract][Full Text] [Related]
19. Associations of serum insulin-like growth factor-I and insulin-like growth factor-binding protein 3 levels with biomarker-calibrated protein, dairy product and milk intake in the Women's Health Initiative. Beasley JM; Gunter MJ; LaCroix AZ; Prentice RL; Neuhouser ML; Tinker LF; Vitolins MZ; Strickler HD Br J Nutr; 2014 Mar; 111(5):847-53. PubMed ID: 24094144 [TBL] [Abstract][Full Text] [Related]
20. Plasma C-peptide, insulin-like growth factor-I, insulin-like growth factor binding proteins and risk of colorectal cancer in a nested case-control study: the Japan public health center-based prospective study. Otani T; Iwasaki M; Sasazuki S; Inoue M; Tsugane S; Int J Cancer; 2007 May; 120(9):2007-12. PubMed ID: 17266031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]